Ac-IEPD-AFC
CAS: 1135417-31-0
Rif. 3D-KVB41731
| 1mg | Fuori produzione | ||
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione |
Informazioni sul prodotto
Ac-IEPD-AFC is a small molecule that has been shown to have significant activity against cancer. Ac-IEPD-AFC is currently in preclinical trials for the treatment of various types of cancer, including pancreatic, lung, and brain cancers. The compound works by binding to the enzyme CD38 and inhibiting its enzymatic activity. This inhibition leads to an increase in intracellular calcium levels and activation of downstream signaling pathways, which can lead to cell death. Ac-IEPD-AFC also binds to other enzymes such as caspase 8 and granzyme B, which are involved in apoptosis pathways. Ac-IEPD-AFC has been shown to be a potential biomarker for a range of cancers due to its ability to be detected using fluorescence microscopy techniques and its capacity for visualization through confocal microscope imaging.
